Bloomberg -- Sanofi-Aventis SA extended its $18.5 billion takeover offer for Genzyme Corp. again, giving France’s biggest drugmaker more time to reach an agreement with the U.S. biotechnology company.
Bloomberg -- Sanofi-Aventis SA extended its $18.5 billion takeover offer for Genzyme Corp. again, giving France’s biggest drugmaker more time to reach an agreement with the U.S. biotechnology company.
